This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

New Study Reveals That Physicians Embrace Patient Self-Tracking

NEW YORK, April 11, 2013 /PRNewswire/ -- In 2013, 70 percent of physicians report that at least one of their patients is sharing health measurement data with them, according to the new Taking the Pulse® U.S. 2013 study from healthcare market research and advisory firm Manhattan Research. However, the methods patients use to share their health measurements with healthcare professionals remain primarily low-tech. The most common forms used by patients are handwriting the data or giving the physician a printout of their information. This year's Taking the Pulse ® U.S. study surveyed 2,950 U.S. practicing physicians online in Q1 2013 across more than 25 specialties.


Moreover, physicians' attitudes toward patients tracking their data are positive. Nearly three-quarters of physicians agree that self-tracking leads to better patient outcomes.

"Self-tracking is already a part of the care paradigm and its prevalence is going to accelerate rapidly as digital connection, payment reform, and outcome-focused delivery make advances," said James Avallone, Director of Physician Research at Manhattan Research. "We are seeing physician attitudes toward self-tracking aligning with policy, which is encouraging for all stakeholders involved." 

Upcoming Webinar! Taking the Pulse ® U.S. 2013 Thursday, April 18 at 11am ET President Meredith Ressi is hosting a webinar April 18th at 11am ET for those interested in learning more about the study as well as highlights from the new data. For more information about the webinar and to register, please visit

About Taking the Pulse ® U.S. 2013Taking the Pulse ® U.S. is Manhattan Research's annual market research study and syndicated advisory service focused on how U.S. physicians use the Internet, digital media, mobile devices and other technologies for professional purposes and patient interaction. Taking the Pulse ® U.S. 2013 was fielded online among 2,950 U.S. practicing physicians in Q1 2013. The data can be segmented across a variety of target specialist audiences, including PCPs, pediatricians, cardiologists, oncologists, gastroenterologists and OB/GYNs. For more information, please visit

About Manhattan ResearchManhattan Research, a Decision Resources Group company, conducts annual research studies covering digital health trends among healthcare professionals and consumers in the Americas, Europe, and Asia. Broad research can be segmented by target specialist and therapeutic audiences. For more information please contact, call 1.888.680.0800, ext 2, or visit

About Decision Resources GroupDecision Resources Group is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources Group at

All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.

For more information, contact:

Manhattan Research Stephanie Cooper212-255-1368

SOURCE Manhattan Research

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,813.39 +1.20 0.01%
S&P 500 2,088.87 -0.27 -0.01%
NASDAQ 5,116.1430 +13.3350 0.26%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs